New Study Reveals Low-Dose Radiation as a Promising Alternative for Knee Osteoarthritis Relief

Millions suffering from knee osteoarthritis often face limited options, ranging from reliance on medications with fading effectiveness to undergoing surgery with lengthy recovery times. However, recent clinical research introduces an unexpected and accessible third path.

Presented at the American Society for Radiation Oncology’s (ASTRO) 2025 Annual Meeting in San Francisco, the study demonstrates that a single treatment course of low-dose radiation therapy can greatly alleviate knee discomfort and boost joint function in individuals with mild to moderate osteoarthritis. The procedure involves a radiation dose less than 5% of what’s used for cancer treatments, administered over six brief sessions spanning several weeks. Many participants reported noticeable benefits within just four months.

While it may seem surprising or even risky to use radiation for joint pain, this approach has long been practiced in countries such as Germany, Austria, and parts of Spain. Yet it remains relatively unknown in the United States and Asia, with few rigorous trials to validate its effectiveness. This Korean-led research significantly advances the evidence supporting low-dose radiation as a safe and potentially game-changing therapy.

Add Cosmo Herald as a Preferred Source

Precise Dosage Yields Clear Improvement

The trial recruited 114 patients diagnosed with mild or moderate knee osteoarthritis from three academic medical centers in South Korea. Participants were randomly assigned to receive a placebo (simulated treatment), an extremely low radiation dose (0.3 Gray), or a slightly higher but still minimal dose (3 Gray). All underwent six treatment sessions resembling typical radiation therapy, though only two groups actually received the radiation.

After four months, 70% of those treated with 3 Gray showed significant improvement in at least two of three key factors: pain relief, physical mobility, and overall health evaluation. In comparison, only 42% of the placebo group experienced similar benefits, according to Dr. Byoung Hyuck Kim, leading the study and serving as an assistant professor at Seoul National University College of Medicine and radiation oncologist at Boramae Medical Center.

The improvements were notable, with participants reporting reduced joint stiffness and enhanced movement, despite restrictions on additional pain management. During the study, only acetaminophen was permitted to ensure the results were directly attributable to the radiation treatment rather than other medications. “We wanted to eliminate any influence from stronger painkillers,” Dr. Kim explained.

Reevaluating a Neglected Therapeutic Approach

Radiation commonly conjures images of cancer treatment, making its use for arthritis surprising. However, in nations like Germany, low-dose radiation therapy is a recognized method for relieving joint pain, endorsed by guidelines and health insurance providers. The administered doses are minimal, presenting no significant risk of long-term adverse effects, especially since the targeted joints are distant from critical organs.

Despite this, the approach has not gained traction in places like the U.S. and South Korea, mainly because of insufficient robust clinical evidence. Most earlier investigations lacked appropriate control groups or used observational designs, complicating efforts to distinguish true therapeutic effects from placebo responses. What sets this study apart is its sham-controlled methodology paired with strict limits on pain medication use, effectively reducing placebo-related distortions.

Previous research has documented placebo response rates as high as 40% in osteoarthritis trials, particularly when injections are involved. The placebo group in this trial fell within that range. “This was anticipated,” noted Dr. Kim. “But it’s the substantial improvements in the treatment group that truly matter.”

Not a Permanent Fix, But a Valuable Option

Low-dose radiation will not regenerate damaged cartilage or reverse chronic joint degeneration, nor will it eliminate the need for surgery in severe cases. However, for individuals in early to moderate stages of osteoarthritis—where inflammation heavily contributes to pain and joint stability remains largely intact—it could provide meaningful symptom relief.

“This treatment isn’t a cure,” Dr. Kim acknowledged, “but it can delay surgery by several years for some patients and might even help others avoid it entirely.” He emphasized the importance of collaborative decision-making, suggesting that radiation therapy be used alongside weight management, physical therapy, and other conservative strategies rather than as a standalone solution.

This intermediate option fills a critical gap between medications and surgery, offering hope to many who struggle with persistent knee pain. For patients who cannot tolerate standard pain relievers or have found injections ineffective, low-dose radiation therapy could represent a much-needed new avenue in chronic joint pain treatment.